Streamlining Atopic Dermatitis (AD) Diagnosis and Treatment in Primary Care

EP: 1.Atopic Dermatitis (AD) Across Ages: Identifying and Treating Flares in Children and Adults

Now Viewing

EP: 2.Streamlining Atopic Dermatitis (AD) Diagnosis and Treatment in Primary Care

EP: 3.Choosing the Right Topical Therapy for Patients With Atopic Dermatitis (AD): Balancing Risk and Efficacy

EP: 4.Treating Atopic Dermatitis (AD) With Topical PDE4 Inhibitors

EP: 5.Other Topical Options to Treat Atopic Dermatitis (AD): Topical JAK Inhibitors and AhR Agonists

EP: 6.Factors that Impact Therapy Decisions for Atopic Dermatitis (AD)

EP: 7.Collaborating for Better Atopic Dermatitis (AD) Care: How Primary Care and Dermatology Can Work Together

EP: 8.Summarizing Topical Options: Treating Atopic Dermatitis (AD) Across Every Age

EP: 9.Closing Thoughts with Patient Cases: Disease Control With Modern Therapies

Streamlining Atopic Dermatitis (AD) Diagnosis and Treatment in Primary Care

Diagnostic Approach

• Diagnosis primarily clinical based on characteristic morphology and distribution of lesions
• Key diagnostic features: pruritus, typical morphology (erythema, papules, vesicles), chronic/relapsing course
• UK Working Party criteria useful in primary care: history of flexural involvement, onset before age 2, history of dry skin, personal/family history of atopy

Assessment Tools

• EASI (Eczema Area and Severity Index): objective measurement of extent and severity
• POEM (Patient-Oriented Eczema Measure): validated patient-reported outcome measure
• DLQI/CDLQI: quality of life assessment tools for adults and children

Treatment Algorithm

• Mild Disease: Regular emollients plus low-potency TCS for flares
• Moderate Disease: Regular emollients, moderate-potency TCS, consider TCIs for sensitive areas
• Severe Disease: Intensive topical therapy, consider short-term phototherapy or referral for systemic therapy

Practical Management Tips

• Emollient Strategy: Apply liberally (500g-1kg weekly), select patient-preferred formulations, prescribe sufficient quantities
• TCS Application: Fingertip unit guidance, apply once daily until resolution plus 48 hours
• Infection Management: Recognize signs of secondary infection, targeted antimicrobial therapy when indicated

Referral Criteria

• Diagnostic uncertainty
• Inadequate response to optimized topical therapy
• Severe/widespread disease
• Significant impact on quality of life
• Suspected contact dermatitis requiring patch testing

Primary Care Optimization

• Structured follow-up appointments (2-4 weeks after initial presentation)
• Standardized educational materials for patients/caregivers
• Electronic templates for consistent documentation and treatment planning
• Clear care pathways between primary care and dermatology

Prevention Strategies

• Proactive maintenance therapy on previously affected sites
• Environmental modifications: dust mite reduction, appropriate clothing choices
• Avoidance of identified triggers
• Regular skin care routine even during remission phases

Emerging Considerations

• Point-of-care testing for specific IgE when relevant
• Telemedicine options for follow-up and monitoring
• Integrated care models with nurse practitioners and pharmacists